Financial Toxicity in Cancer Care | Oncology Stories
Financial Toxicity: A Debilitating Side Effect of Cancer Care
The unspoken struggle of many people living with cancer lies in the financial burdens they face and the tough choices they must make for themselves and their loved ones as a result. Financial toxicity – the adverse financial effects of a cancer diagnosis – extends well beyond medical costs and is inclusive of daily living expenses including housing, transportation and food. How can the oncology community come together to address a health inequity this vast and complex for patients worldwide?
During a fireside chat for The Atlantic, Takeda Oncology’s Dion Warren, Vice President, Head, U.S. Oncology Business Unit, met with Carla Tardif, CEO of Family Reach, to answer this important question and discuss how partnerships can play a key role in addressing financial disparities among people living with cancer.
Related Stories
Living is More Than Surviving: Balancing Clinical Outcomes with Patient Impact in Cancer Care
Balancing clinical outcomes with quality of life. Explore how Takeda Oncology prioritizes patient impact alongside survival rates in cancer treatment approaches.
Beyond Early Detection: Bridging the Gaps in mCRC Support
Beyond early detection: Learn how Takeda Oncology partners with patient advocacy organizations to bridge care gaps in metastatic colorectal cancer support.
Cancer Treatment is More Than Medicine
Cancer treatment extends beyond clinical care. Explore how Takeda Oncology supports patients through mental health, well-being, and holistic approaches to care.